Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F4D6L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,699
Award facts
- Contract value 100% obligated
- $36,699.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,699.19 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML pen/milliliter on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
SKYRIZI is a biologic immunosuppressant medication used primarily in the treatment of psoriasis and other inflammatory skin conditions. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills extensive pharmaceutical supply requirements for military and veteran healthcare systems through its DLA agreements. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with specialized brand-name pharmaceutical products across multiple therapeutic domains, leveraging its comprehensive global pharmaceutical supply vehicle to meet military medical readiness requirements.
Quick answers
Who was awarded contract SPE2DR26F4D6L?
SPE2DR26F4D6L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F4D6L worth?
The government has obligated $36,699 on SPE2DR26F4D6L.
Is contract SPE2DR26F4D6L an order under another contract?
Yes. SPE2DR26F4D6L is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D6L competed?
The extent of competition for SPE2DR26F4D6L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award